Navigation Links
SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years
Date:12/8/2011

es Litigation Reform Act of 1995.  These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," predict," "opportunity" and "should," among others.  There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.  These factors include, but are not limited to, the response from the United States Food and Drug Administration, or FDA, to our resubmission of the New Drug Application, or NDA, for Qnexa for the treatment of obesity, including weight loss and maintenance of weight loss, recommended for obese patients (BMI >30 kg/m2), or overweight patients (BMI >27 kg/m2) with weight-related co-morbidities such as hypertension, type 2 diabetes, dyslipidemia, or central adiposity (abdominal obesity), with a contraindication that excludes the use of Qnexa by women of child-bearing potential; the timing and results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy; the reliability of the electronic medical claims healthcare databases used in the FORTRESS study; the FDA's interpretation of and agreement with the information VIVUS submitted relating to teratogenicity and cardiovascular safety; the FDA's interpretation of the data from our SEQUEL study (OB-305) and Sleep Apnea study (OB-204); that we may be required to conduct additional prospective studies or retrospective observational studies or to provide further analysis of clinical trial data; our response to questions and requests for additional information including additional pre-clinical or clinical studies from the European Medicines Agency, or EMA, and the Committee for Medicinal Products for Human Use, or CHMP, of the Marketing Authorization Application, or MAA, for Qnexa; the results of external studies to assess the t
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
2. Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting
3. SequelMed EMR Version 8 Certified by Ohio Board of Pharmacy
4. Sequel Systems, Inc. Meaningful Use EHR Receives ONC-ATCB 2011/2012 Certification
5. Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
6. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
7. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
10. GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market
11. GiiResearch.com: Insulin Pumps - Availability of Reimbursement and Favorable Clinical Trial Data to Drive Market Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers ... technologies must be able to protect their ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) ... of the Medical Device Industry, it steadfastly ... sectors of cases involving IP infringement. This ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... market research report is available in its ... Dermatitis - India Drug Forecast and Market ... PharmaPoint: Atopic Dermatitis - ... 2022 Summary,Although the past decade ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... Institute, the leading provider of specialized training solutions ... subsidiary of Campbell Alliance, announced today the completion ... Area Essentials™ e-course series.  This series ... biotech R&D and commercial professionals.  It includes 155 ...
... Calif., June 20, 2011 Inogen has been honored ... the Inogen One Portable Oxygen Concentrator.  The Medical Design ... exclusively recognizes contributions and advances in the design of ... by Goleta, California based Inogen, Inc. is used to ...
Cached Medicine Technology:Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma 2Inogen One Wins Gold Medical Design Excellence Award 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... from a family involved in several human diseases is ... new research has found, suggesting that the protein might ... ClC-3 channel, a passageway that allows negatively-charged chloride ions ... circulating insulin of normal mice, according to research published ...
... ... caregivers to voice their concerns about their own health as well as the people who ... ... 2009 -- The ALS Association is encouraging caregivers to voice their concerns about their own ...
... Confirming the full impact of the global recession, philanthropic giving ... 2.9 percent -- or about $241 million -- to $8.6 ... a dramatic 12.9 percent, to total $1.07 billion, according to ... for Healthcare Philanthropy (AHP). , "The poor overall results for ...
... at Arizona State University will use the laws of physics ... treating cancer as a disease and seeking a cure, ASU ... them the way a physicist would, using simple variables like ... a new research center at Arizona State University one ...
... Semen isn,t the only way men spread virus during sex, ... New research suggests that sperm, not just semen, can transmit ... body and, in fact, sperm may play a major role ... HIV, the virus that causes AIDS, can spread the disease ...
... NEW YORK, Oct. 26 Adam Kluger Public Relations ( ... MD ( www.drdennismd.com ) has retained the New ... to promote his psychiatric practice which specializes in sexology, sexual ... sexuality in all its diverse expression should be celebrated. The ...
Cached Medicine News:Health News:Protein critical for insulin secretion may be contributor to diabetes 2Health News:Protein critical for insulin secretion may be contributor to diabetes 3Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 2Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 3Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 4Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 5Health News:The ALS Association Cares for Those Who Care the Most in New Campaign 6Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 2Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 3Health News:Charitable Giving for U.S. Health Care Rises a Tepid $241 Million in 2008, While Canadian Charitable Giving Plunges 13 Percent, Association for Healthcare Philanthropy Reports 4Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 2Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 3Health News:Physical scientists at Arizona State University will apply laws of physics in cancer fight 4Health News:Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr. Dennis Lin, MD to Their All-Star Health and Medical Client Roster 2
... Kubtec introduces a breakthrough in specimen radiography. ... provide up to 65,536 shades of gray in ... capture the smallest changes in density that heretofore ... including digital detectors from 2 x 2 to ...
The Triage Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment...
... is an affordable path to Sonesta ... seat, and back adjustments. Packaged with ... full line of Sonesta add-ons, allowing ... for your needs; complete Sonesta flexibility ...
... The Sonesta 6202 is ... Packaged with our most popular ... equipped for a myriad of ... powerful (yet quiet) motors allow ...
Medicine Products: